Qualigen Therapeutics, Inc. (QLGN)
USD 3.9
(-4.88%)
USD 3.9
(-4.88%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2020 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.3 Million | -13.24 Million | -14.73 Million | -9.75 Million | 57.33 Thousand | -13.33 Million |
| Net Income | -12.13 Million | -21.03 Million | -17.89 Million | -20.41 Million | -1.78 Million | -16.86 Million |
| Depreciation & Amortization | 4495.00 | 375.6 Thousand | 338.27 Thousand | 293.36 Thousand | 216.6 Thousand | 5700.00 |
| Deferred income taxes | 495.89 Thousand | -271.62 Thousand | -4.78 Million | -3.02 Million | 588.11 Billion | 893.82 Thousand |
| Stock-based compensation | 1.09 Million | 5.48 Million | 5.69 Million | 2.8 Million | 7866.00 | 32.6 Thousand |
| Change in working capital | 1.11 Million | -1.43 Million | 2.21 Million | -2.12 Million | 1.52 Million | 3.79 Million |
| Other non-cash items | -882.79 Thousand | 3.63 Million | 101.75 Thousand | 9.68 Million | -588.11 Billion | -3.37 Million |
| Investing Cash Flow | 4.21 Million | -183.76 Thousand | -141.36 Thousand | -160.55 Thousand | -194.47 Thousand | -6.97 Million |
| Investments in PPE | 10.3 Million | -319.11 Thousand | -141.36 Thousand | -210.19 Thousand | -194.47 Thousand | -2008.00 |
| Acquisitions | - | 135.35 Thousand | - | - | - | - |
| Investment purchases | - | 9439.00 | 8.82 Million | - | - | -6.96 Million |
| Sales/Maturities of investments | - | - | - | - | 6998.54 Billion | - |
| Other Investing Activities | 4.21 Million | -9439.00 | -8.82 Million | 49.63 Thousand | -6998.54 Billion | -203.9 Thousand |
| Financing Cash Flow | -550 Thousand | 2.91 Million | 8.43 Million | 33.76 Million | 165.14 Thousand | 5.48 Million |
| Debt repayment | -550 Thousand | -2.9 Million | -138.73 Thousand | -165.14 Thousand | -165.92 Thousand | -1.34 Million |
| Dividends payments | - | - | - | - | - | -3256.00 |
| Common Stock Repurchased | - | -505.00 | - | - | - | - |
| Common Stock Issuance | - | 7173.00 | 8.82 Million | - | -49.62 Billion | 6 Million |
| Other Financing Activities | -550 Thousand | 2.91 Million | -247.45 Thousand | 33.59 Million | 49.62 Billion | -512.53 Thousand |
| Accounts receivables | - | 417.7 Thousand | 41.25 Thousand | 545.58 Thousand | 129.34 Thousand | -54.45 Thousand |
| Accounts payables | 1.6 Million | -33.39 Thousand | 385.45 Thousand | - | 482.17 Thousand | 3.16 Million |
| Inventory | - | -637.41 Thousand | 111.42 Thousand | -326.06 Thousand | 57.91 Thousand | 288.63 Thousand |
| Other working capital | -491.84 Thousand | -1.17 Million | 1.67 Million | -2.33 Million | 852.72 Thousand | 684.67 Thousand |
| Cash at beginning of period | 3.16 Million | 17.53 Million | 23.97 Million | 125.12 Thousand | 125.12 Thousand | 22.63 Million |
| Cash at end of period | 401.8 Thousand | 7.04 Million | 17.53 Million | 153.12 Thousand | 153.12 Thousand | 7.81 Million |
| Capital Expenditure | 10.3 Million | -319.11 Thousand | -141.36 Thousand | -210.19 Thousand | -194.47 Thousand | -2008.00 |
| Effect of forex changes on cash | 3.87 Million | 22.63 Thousand | - | -23.81 Million | -6112.28 Billion | -1.00 |
| Net cash flow / Change in cash | -2.76 Million | -10.49 Million | -6.43 Million | 27.99 Thousand | 27.99 Thousand | -14.81 Million |
| Free Cash Flow | - | -13.56 Million | -14.87 Million | -9.96 Million | -137.14 Thousand | -13.33 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.47 Million | -2.03 Million | -12.13 Million | -2.46 Million | -2.39 Million | -3.5 Million |
| Depreciation & Amortization | 219.06 Thousand | - | 4495.00 | 4495.00 | -239.09 Thousand | 122.78 Thousand |
| Deferred income taxes | - | - | 495.89 Thousand | 572.47 Thousand | -150.36 Thousand | -410.66 Thousand |
| Stock-based compensation | 33.08 Thousand | 58.65 Thousand | 1.09 Million | 69.69 Thousand | 122.69 Thousand | 653.91 Thousand |
| Change in working capital | 275.34 Thousand | 602.84 Thousand | 1.11 Million | 356.08 Thousand | 141.37 Thousand | -40.85 Thousand |
| Other non-cash items | -325.87 Thousand | 1.06 Million | -882.79 Thousand | -4.2 Million | 3.44 Million | 254.18 Thousand |
| Investing Cash Flow | 350 Thousand | - | 4.21 Million | 235.4 Thousand | 4.22 Million | -48.4 Thousand |
| Investments in PPE | 2.00 | - | - | - | 246.41 Thousand | -48.4 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 350 Thousand | - | 4.21 Million | 235.4 Thousand | 3.98 Million | - |
| Financing Cash Flow | 1.15 Million | 475 Thousand | -550 Thousand | -110 Thousand | -440 Thousand | -1.00 |
| Debt repayment | -1 Million | -475 Thousand | -550 Thousand | -110 Thousand | -440 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 150 Thousand | - | - | - | - | - |
| Other Financing Activities | 1.15 Million | - | -550 Thousand | -110 Thousand | - | - |
| Accounts receivables | - | - | - | - | - | -255.25 Thousand |
| Accounts payables | 52.56 Thousand | -421.64 Thousand | 1.6 Million | 651.15 Thousand | 52.51 Thousand | 856.61 Thousand |
| Inventory | - | - | - | - | - | -108.76 Thousand |
| Other working capital | 222.78 Thousand | 1.02 Million | -491.84 Thousand | -295.06 Thousand | 88.86 Thousand | -533.44 Thousand |
| Cash at beginning of period | 543.21 Thousand | 401.8 Thousand | 3.16 Million | 2.07 Million | 1.34 Million | 4.36 Million |
| Cash at end of period | 118.68 Thousand | 543.21 Thousand | 401.8 Thousand | 401.8 Thousand | 2.07 Million | 1.34 Million |
| Capital Expenditure | 2.00 | - | - | - | 246.41 Thousand | -48.4 Thousand |
| Effect of forex changes on cash | - | - | 3.87 Million | 3.87 Million | -115.8 Thousand | -44.51 Thousand |
| Net cash flow / Change in cash | -424.53 Thousand | 141.41 Thousand | -2.76 Million | -1.67 Million | 726.75 Thousand | -3.02 Million |
| Free Cash Flow | -1.47 Million | -783.58 Thousand | -10.3 Million | -5.67 Million | 1.17 Million | -2.97 Million |
0KXM
0I4T
ECLERX
BALMLAWRIE
JISLJALEQS
SGRY